The Usefulness of White Blood Cell Inflammatory Parameters in Children With Systemic Lupus Erythematosus

• by Butsabong Lerkvaleekul, Nongnuch Sirachainan, Duantida Songdej, Karan Paisooksantivatana, Pawadee Chinudomwong, Soamarat Vilaiyuk

• October 13, 2026

Neighborhood Socioeconomic Status and Short-Term Functional Outcomes in Systemic Lupus Erythematosus

• by Baljeet Rai, Jessica Fitzpatrick, Jing Li, Eric Roberts, Patricia Katz, Laura Plantinga, Gabriela Schmajuk, Jinoos Yazdany

• May 20, 2026

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

• by Kathryn Wighton

• June 5, 2026

• 4 min

Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time

• by Loqmane Seridi, Eugene Myshkin, Erika Noss, Sheng Gao, Julio Molineros, Carolyn Cuff, Dawn Waterworth, Matthew J. Loza

• July 1, 2026